Elevated serum levels of bone morphogenetic protein-9 are associated with better outcome in AQP4-IgG seropositive NMOSD
Abstract Lymphatic drainage in the central nervous system is regulated by meningeal lymphatic vasculature, and recurrent neuroinflammation alters lymphatic vessel remodeling. Patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (AQP4 + NMOSD) were reported to demonstrat...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2023-03-01
|
| Series: | Scientific Reports |
| Online Access: | https://doi.org/10.1038/s41598-023-30594-z |
| _version_ | 1797864938505502720 |
|---|---|
| author | Hiroki Masuda Masahiro Mori Akiyuki Uzawa Tomohiko Uchida Mayumi Muto Ryohei Ohtani Reiji Aoki Satoshi Kuwabara |
| author_facet | Hiroki Masuda Masahiro Mori Akiyuki Uzawa Tomohiko Uchida Mayumi Muto Ryohei Ohtani Reiji Aoki Satoshi Kuwabara |
| author_sort | Hiroki Masuda |
| collection | DOAJ |
| description | Abstract Lymphatic drainage in the central nervous system is regulated by meningeal lymphatic vasculature, and recurrent neuroinflammation alters lymphatic vessel remodeling. Patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (AQP4 + NMOSD) were reported to demonstrate worse outcomes compared with patients with anti-myelin oligodendrocyte glycoprotein-associated disorders (MOGAD). This study aimed to investigate the serum cytokines relevant to vascular remodeling after attacks and their prognostic role in patients with AQP4 + NMOSD. This study measured the serum levels of 12 cytokines relevant to vascular remodeling, including bone morphogenetic protein-9 (BMP-9) and leptin, in 20 patients with AQP4 + NMOSD and 17 healthy controls (HCs). Disease controls included 18 patients with MOGAD. Serum and cerebrospinal fluid interleukin-6 levels were also measured. Clinical severity was evaluated with Kurtzke’s Expanded Disability Status Scale (EDSS). Compared with HCs, patients with AQP4 + NMOSD showed higher BMP-9 (median; 127 vs. 80.7 pg/mL; P = 0.0499) and leptin levels (median; 16,081 vs. 6770 pg/mL; P = 0.0224), but not those with MOGAD. Better improvement in EDSS at 6 months was associated with baseline BMP-9 levels in patients with AQP4 + NMOSD (Spearman’s rho = − 0.47; P = 0.037). Serum BMP-9 is upregulated at relapse and may contribute to vascular remodeling in AQP4 + NMOSD. Serum BMP-9 levels could predict clinical recovery 6 months after the attack. |
| first_indexed | 2024-04-09T23:00:02Z |
| format | Article |
| id | doaj.art-e5008498960642a48fbdcea2dcd6858b |
| institution | Directory Open Access Journal |
| issn | 2045-2322 |
| language | English |
| last_indexed | 2024-04-09T23:00:02Z |
| publishDate | 2023-03-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Scientific Reports |
| spelling | doaj.art-e5008498960642a48fbdcea2dcd6858b2023-03-22T11:02:36ZengNature PortfolioScientific Reports2045-23222023-03-011311910.1038/s41598-023-30594-zElevated serum levels of bone morphogenetic protein-9 are associated with better outcome in AQP4-IgG seropositive NMOSDHiroki Masuda0Masahiro Mori1Akiyuki Uzawa2Tomohiko Uchida3Mayumi Muto4Ryohei Ohtani5Reiji Aoki6Satoshi Kuwabara7Department of Neurology, Graduate School of Medicine, Chiba UniversityDepartment of Neurology, Graduate School of Medicine, Chiba UniversityDepartment of Neurology, Graduate School of Medicine, Chiba UniversityDepartment of Neurology, Graduate School of Medicine, Chiba UniversityDepartment of Neurology, Graduate School of Medicine, Chiba UniversityDepartment of Neurology, Graduate School of Medicine, Chiba UniversityDepartment of Neurology, Graduate School of Medicine, Chiba UniversityDepartment of Neurology, Graduate School of Medicine, Chiba UniversityAbstract Lymphatic drainage in the central nervous system is regulated by meningeal lymphatic vasculature, and recurrent neuroinflammation alters lymphatic vessel remodeling. Patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (AQP4 + NMOSD) were reported to demonstrate worse outcomes compared with patients with anti-myelin oligodendrocyte glycoprotein-associated disorders (MOGAD). This study aimed to investigate the serum cytokines relevant to vascular remodeling after attacks and their prognostic role in patients with AQP4 + NMOSD. This study measured the serum levels of 12 cytokines relevant to vascular remodeling, including bone morphogenetic protein-9 (BMP-9) and leptin, in 20 patients with AQP4 + NMOSD and 17 healthy controls (HCs). Disease controls included 18 patients with MOGAD. Serum and cerebrospinal fluid interleukin-6 levels were also measured. Clinical severity was evaluated with Kurtzke’s Expanded Disability Status Scale (EDSS). Compared with HCs, patients with AQP4 + NMOSD showed higher BMP-9 (median; 127 vs. 80.7 pg/mL; P = 0.0499) and leptin levels (median; 16,081 vs. 6770 pg/mL; P = 0.0224), but not those with MOGAD. Better improvement in EDSS at 6 months was associated with baseline BMP-9 levels in patients with AQP4 + NMOSD (Spearman’s rho = − 0.47; P = 0.037). Serum BMP-9 is upregulated at relapse and may contribute to vascular remodeling in AQP4 + NMOSD. Serum BMP-9 levels could predict clinical recovery 6 months after the attack.https://doi.org/10.1038/s41598-023-30594-z |
| spellingShingle | Hiroki Masuda Masahiro Mori Akiyuki Uzawa Tomohiko Uchida Mayumi Muto Ryohei Ohtani Reiji Aoki Satoshi Kuwabara Elevated serum levels of bone morphogenetic protein-9 are associated with better outcome in AQP4-IgG seropositive NMOSD Scientific Reports |
| title | Elevated serum levels of bone morphogenetic protein-9 are associated with better outcome in AQP4-IgG seropositive NMOSD |
| title_full | Elevated serum levels of bone morphogenetic protein-9 are associated with better outcome in AQP4-IgG seropositive NMOSD |
| title_fullStr | Elevated serum levels of bone morphogenetic protein-9 are associated with better outcome in AQP4-IgG seropositive NMOSD |
| title_full_unstemmed | Elevated serum levels of bone morphogenetic protein-9 are associated with better outcome in AQP4-IgG seropositive NMOSD |
| title_short | Elevated serum levels of bone morphogenetic protein-9 are associated with better outcome in AQP4-IgG seropositive NMOSD |
| title_sort | elevated serum levels of bone morphogenetic protein 9 are associated with better outcome in aqp4 igg seropositive nmosd |
| url | https://doi.org/10.1038/s41598-023-30594-z |
| work_keys_str_mv | AT hirokimasuda elevatedserumlevelsofbonemorphogeneticprotein9areassociatedwithbetteroutcomeinaqp4iggseropositivenmosd AT masahiromori elevatedserumlevelsofbonemorphogeneticprotein9areassociatedwithbetteroutcomeinaqp4iggseropositivenmosd AT akiyukiuzawa elevatedserumlevelsofbonemorphogeneticprotein9areassociatedwithbetteroutcomeinaqp4iggseropositivenmosd AT tomohikouchida elevatedserumlevelsofbonemorphogeneticprotein9areassociatedwithbetteroutcomeinaqp4iggseropositivenmosd AT mayumimuto elevatedserumlevelsofbonemorphogeneticprotein9areassociatedwithbetteroutcomeinaqp4iggseropositivenmosd AT ryoheiohtani elevatedserumlevelsofbonemorphogeneticprotein9areassociatedwithbetteroutcomeinaqp4iggseropositivenmosd AT reijiaoki elevatedserumlevelsofbonemorphogeneticprotein9areassociatedwithbetteroutcomeinaqp4iggseropositivenmosd AT satoshikuwabara elevatedserumlevelsofbonemorphogeneticprotein9areassociatedwithbetteroutcomeinaqp4iggseropositivenmosd |